Spun out of the University of California-San Diego, AntiCancer, Inc. is long established biotechnology company. developing drugs for cancer based on genetic engineering and targeting cancer specific metabolic defects. Based in San Diego, with offices and laboratories in Seoul, Beijing, Nanjing and Tokyo, the firm markets the leading mouse models for cancer research, drug development and drug discovery in pharma, biotech and academia. AntiCancer is also developing its proprietary tumor-targeting bacteria as a general therapeutic for cancer. In addition, AntiCancer is developing pluripotent stem cells from the hair follicle for regenerative medicine. AntiCancer also markets unique recombinant-enzyme-based diagnostics. The company provides Oncobriteâ, a small-animal imaging technology; MetaMouseâ and ANGIOMOUSEâ that are mouse models of human cancer; Histoculture Drug Response Assay, an individualized cancer therapy; Oncase-PEGâ, a recombinant protein that depletes methionine in tumors; stem cells for general regenerative medicine; tumor-targeting bacteria; and Dermatek, a liposome-based hair-follicle targeting technology. It also offers Enzymatic Homocysteine, Enzymatic B6, and Enzymatic cysteine assa
